But for patients, doctors, Medicare and other insurers, the drug's arrival will pose a conundrum. That is because the medicine, Lucentis, is expected to be 10 to 100 times as expensive as a similar drug that many ophthalmologists say is every bit as good.
Posts
The thought that counts
3 hours ago
1 comment:
This is a poker problem. It all has to do with expected value.
Assume for calcualtions that the price of a dose of Lucentis is $2000 (pL=2000) and Avastin is $50 (pA=50) We then have to come up with some fudge factor for how efficacious each drug is. Without even going through the exercise, it is clear at first glance that pL=40*pA.
Is Lucentis 40 times "better" than Avastin?
If any Retina docs read this blog, I challenge you to not use Lucentis as long as Avastin is available.
Post a Comment